Client News
AdhereTech Appoints Innes Meldrum as President and Chief Executive Officer
6th September 2023
Proteros biostructures and Orion Pharma agree on a long-term multi-target collaboration including the assembly of a joint novel and unique HTS small-molecule screening library with the full chemistry support of Enamine
6th September 2023
Element Materials unveils fully integrated pharma services platform, strengthening its expanding Life Sciences Division
5th September 2023
invIOs starts further clinical trial of APN401, novel cell therapy against solid cancers, and secures major Austrian grant funding
5th September 2023
Mainz Biomed Announces Strategic Partnership with Ärztliches Labor Dr. Buhlmann, Expanding Footprint in German Market
5th September 2023
iOmx Therapeutics appoints Dr. Nils Peter Debus as Chief Business Officer
5th September 2023
InflaRx’s Marketing Authorization Application (MAA) for Vilobelimab for Treatment of Critically Ill COVID-19 Patients under Review by European Medicines Agency (EMA)
30th August 2023
Abivax Appoints Patrick Malloy as Senior Vice President Investor Relations
23rd August 2023
AiCuris Received 30 Million Euros Milestone Payment from Licensing Partner MSD Following U.S. FDA Approval of PREVYMIS® (letermovir) in Second Indication
23rd August 2023
Medigene AG Expands Intellectual Property Rights for its Costimulatory Switch Proteins to Additional Immune Cell Types
23rd August 2023
There is no more content to load